Haiyan Jiang
Company: PointLoma biosciences
Job title: Founder, President and Chief Scientific Officer
Seminars:
Chair’s Closing Remarks 4:00 pm
day: Conference Day Two
Harnessing the Power of the Innate Immunity to Fight Solid Tumor 11:45 am
Developing off-the-shelf allogeneic healthy donor-derived γδ T cell therapy for solid tumor Polyclonal, natural composition of γδ T cell subsets, leveraging the non-redundant functions of diverse subsets Armed and engineered dual CAR targets tumor and immunesupporessive stroma in the TME to optimize anti-tumor potency Gene editing to overcome immune suppression in the solid tumor TMERead more
day: Conference Day One - Track A
Chairman’s Closing Remarks 4:30 pm
day: Conference Day One